People
The People
Governance grade: C+. Real money flows into the stock (CEO Yan Li's family trust controls 38% of equity and ~30% of voting power; the convicted-founder shareholder bought roughly ¥106 million of stock in the past nine months), but the dual-class structure, a one-man Chairman/CEO/COO seat, an over-boarded audit chair, and the lingering shadow of a co-founder's 2015 insider-trading conviction cap the grade.
The People Running This Company
A five-person board oversees a tiny executive cohort: chairman/CEO/COO Yan Li and CFO Fion Zhou are the only named officers. Decision-making is concentrated, succession is unaddressed, and the operating team is thin for a company with ¥4.3 billion of revenue.
Yan Li is the franchise. A Stanford-trained engineer who ran KKR Capstone's China portfolio operations (Haier, China Modern Dairy, China Cord Blood) and held 3G/4G patents at Qualcomm before joining as COO in 2016 and taking the CEO seat 22 months later. He combines technical depth (engineering) with operational discipline (PE) — an unusually well-matched profile for a connected-hardware company. The downside: he holds all three top operating titles (Chairman, CEO, COO) and has no public deputy in place. If he leaves, the bench is essentially Ms. Zhou and a Vice President of Design.
Fion Zhou is overqualified for a ¥4.3bn company, which is both a positive signal of recruiting strength and a flag that her US-listed-CFO track record (Sogou, Alibaba) gives her career optionality elsewhere. She joined the board in December 2023, formally tying her to governance accountability.
Founder's shadow. Co-founder Li Yi'nan (no relation to Yan Li) was convicted of one count of insider trading by the Guangdong Shenzhen Municipal Intermediate People's Court in January 2017, in connection with June 2015 trading in a Shenzhen-listed stock; his prison sentence ended in December 2017. He is explicitly not in management, but his family trust still beneficially owns 38.4% of the equity. The other co-founder, Token Yilin Hu, exited the board but retains 5.5% of shares with 17.0% voting power via trust. The two non-management founder trusts together control ~47% of voting power.
What They Get Paid
Cash compensation is trivially small relative to company size; the entire pay package is equity grants. That is shareholder-friendly in form, but the option strike of US$3.425 (set in 2019) is now so close to the current ~$3 share price that the option overhang has limited motivational asymmetry — RSUs do the real work.
Read: The CEO drew under ¥4 million of cash across the whole executive team in FY2025 — less than US$600 thousand combined — but received a 1.5 million-share RSU grant in January 2025 valued at roughly ¥30 million at the current ADR price. Pay is dominated by equity, equity is dominated by RSUs, and RSUs vest regardless of operating performance. There is no disclosed performance-vesting hurdle. For a company that has lost money for four straight years, the absence of performance conditions on the largest grant in years is the single biggest compensation weakness.
Are They Aligned?
This is the section that decides the report. The headline is mixed: the convicted-founder family trust is the largest economic holder and is buying aggressively in the open market, but the company's dual-class structure means cash-paying public ADR holders effectively never outvote insiders.
Ownership & control
Class B ordinary shares carry four votes per share. The two founder trusts plus the CEO control roughly 60% of voting power on a 14% economic stake combination through Class B alone. Public ADR holders have economic exposure but no realistic path to influence outcomes — a routine red flag for U.S.-listed Chinese ADRs but worth pricing in.
Insider buying: a meaningful tape
The buying tape is very loud. Four open-market purchases by the founder trust totalling roughly ¥106 million across 4.4 million shares between July 2025 and March 2026, with each subsequent buy at a higher price (¥21.7 → ¥27.8 per share). The CFO's March 2026 sale was for 22,113 shares — disclosed as ADS sales to cover RSU tax withholding, not a discretionary disposition.
Two ways to read this. Bullish: the largest economic owner, who has nothing to do with day-to-day operations, is betting roughly ¥106 million of personal capital that the stock is mispriced — and stepping up size, not down. Bearish: that owner has a documented history of insider trading and beneficiary access to a controlling trust whose protectors he can replace from August 2028.
Dilution & capital allocation
The 2018 Plan auto-adds 1.5% of outstanding shares every year to the incentive pool regardless of performance — that's structural ~1.5% annual dilution baked into the cap table. About 11.3 million shares (7.2% of current diluted) are presently under outstanding options and RSUs. No buyback program of size has been announced to offset this. The company spent FY2025 building inventory and product launches, not returning capital — defensible at this stage, but the equity issuance asymmetry is real.
Related-party / VIE
The standard PRC VIE contractual structure is in place (Cayman holding company → WFOE → contractual control of the operating VIE). No related-party transactions of cash significance are disclosed in the FY2025 20-F beyond employment and indemnification agreements and the equity grants tabled above. There is no founder loan, founder real-estate lease, or sibling-vendor arrangement disclosed.
Skin-in-the-game scorecard
Skin-in-the-Game Score (out of 10)
Insider Voting Power
Founder Trust Economic Stake
Why 6.5 and not higher: (1) the CEO's direct economic ownership is only 5.2% of shares; the bigger stake sits in the founder trust whose beneficiary is not in the company; (2) the 1.5%/year automatic plan top-up shows the board has not negotiated dilution discipline; (3) RSUs vest with time, not performance. Why not lower: (1) the convicted-founder beneficiary just put ¥106 million of personal capital into the stock at rising prices; (2) cash compensation is essentially nil — pay is overwhelmingly stock; (3) directors all hold equity, even at small amounts.
Board Quality
A small, formally compliant Nasdaq board (3 of 5 independent) that on paper checks every box and on substance is thinner than it looks.
The real problem is concentration. Five directors, three independents, audit chair sitting on five other listed boards, and a CEO who is also chairman and COO. That structure works fine when the founder is performing — and it has, given the FY2025 31% revenue growth and the volume turnaround — but it offers very little institutional resistance if Mr. Li's judgment ever drifts. The closest things to checks-and-balances are the trust protectors on Yinan Li's holding vehicle and the public disclosure regime; both are external to the board.
Two missing expertises are conspicuous: no director with deep batteries / Li-ion supply chain experience (the company's gross margin is determined here) and no director with retail/distribution experience for the franchised store model that drives China sell-through.
The Verdict
Governance grade: C+.
Skin-in-Game (0–10)
Independent directors
Total directors
Strongest positives:
- The largest economic shareholder bought roughly ¥106 million of stock in the open market over nine months — at rising prices.
- CEO Yan Li's CV (Stanford / Qualcomm / McKinsey / KKR) and the CFO's CV (PwC / Alibaba / Sogou) are well above typical for a company of this size — and both hold meaningful equity.
- Cash compensation is essentially nominal; pay is overwhelmingly stock-based, structurally aligning realised pay with share-price outcomes.
- No reported restatements, no SEC enforcement actions against the company, and no related-party dealings beyond standard employment.
Real concerns:
- Dual-class shares plus founder/trust ownership mean public ADR holders cannot realistically force change.
- The largest economic owner is a convicted insider trader (offence: 2015, served sentence, no longer in management). The conviction was for tipping a friend, not for a fiduciary breach against Niu, but it is documented and material to trust.
- Audit chair Changqing Ye sits on five-plus other listed boards. That is the single most fixable governance issue and the one ISS-style frameworks will flag immediately.
- No performance-vesting on the CEO's January 2025 1.5 million-share RSU grant.
- Chairman/CEO/COO concentration with no disclosed succession plan and no lead independent director.
The one thing that would most likely move the grade:
- Upgrade to B−: appointment of a lead independent director, a stated buyback authorisation, and performance-vesting hurdles on the next CEO RSU grant. The first two are nearly cost-free; the third is a willingness test.
- Downgrade to C−: any related-party transaction with Yinan Li's investment vehicles (Plum Ventures or successor funds), any change to the trust protectors after August 2028 that increases his direct control, or another option re-pricing.